Literature DB >> 20828859

Surgical resection of liver non-small cell lung cancer metastasis: a dual weapon?

Ecaterina Ileana1, Laurent Greillier, Vincent Moutardier, Fabrice Barlesi.   

Abstract

Liver resection for metastases from a colorectal cancer is well established and it is considered the treatment of choice. However, for patients with liver metastases from other carcinomas, the value of resection is incompletely defined and still debated. We report two cases of partial hepatectomies for liver metastases from non-small cell lung cancer leading to different outcomes. A review of the literature suggests that although early reports of similar procedures were not favorable, hepatic resection became a safe procedure, which can sometimes offer a long-term survival and should be considered in selected cases.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20828859     DOI: 10.1016/j.lungcan.2010.08.010

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  7 in total

1.  Hepatectomy for oligo-recurrence of non-small cell lung cancer in the liver.

Authors:  Fumitaka Ishige; Wataru Takayama; Satoshi Chiba; Isamu Hoshino; Hidehito Arimitsu; Hiroo Yanagibashi; Yosuke Iwatate
Journal:  Int J Clin Oncol       Date:  2018-03-06       Impact factor: 3.402

Review 2.  Surgical approach in the oligometastatic patient.

Authors:  Duilio Divisi; Mirko Barone; Gino Zaccagna; Francesca Gabriele; Roberto Crisci
Journal:  Ann Transl Med       Date:  2018-03

3.  Construction and validation of a nomogram for non small cell lung cancer patients with liver metastases based on a population analysis.

Authors:  Ruhan Zhao; Yunnan Dai; Xinyang Li; Cuimin Zhu
Journal:  Sci Rep       Date:  2022-03-07       Impact factor: 4.379

4.  Percutaneous Radiofrequency Ablation Is an Effective Method for Local Control of Liver Metastases From Lung Cancer.

Authors:  Zhong-Yi Zhang; An-Na Jiang; Wei Yang; Kun Yan; Wei Wu; Song Wang; Bin-Bin Jiang; Li-Qi Sun; Kun Zhao; Min-Hua Chen
Journal:  Front Oncol       Date:  2022-04-06       Impact factor: 5.738

Review 5.  Oligometastatic non-small cell lung cancer: Current management.

Authors:  Alicia Román-Jobacho; María Hernández-Miguel; María Jesús García-Anaya; Jaime Gómez-Millán; J A Medina-Carmona; Ana Otero-Romero
Journal:  J Clin Transl Res       Date:  2021-05-27

6.  Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis.

Authors:  Eduardo Castañón; Christian Rolfo; David Viñal; Inés López; Juan P Fusco; Marta Santisteban; Patricia Martin; Leire Zubiri; José I Echeveste; Ignacio Gil-Bazo
Journal:  J Transl Med       Date:  2015-08-07       Impact factor: 5.531

7.  Prognostic effect of liver metastasis in lung cancer patients with distant metastasis.

Authors:  Yijiu Ren; Chenyang Dai; Hui Zheng; Fangyu Zhou; Yunlang She; Gening Jiang; Ke Fei; Ping Yang; Dong Xie; Chang Chen
Journal:  Oncotarget       Date:  2016-08-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.